CAR T-cell Therapy for B-ALL

A panelist discusses how CAR-T cell therapy patient selection involves evaluating disease characteristics like relapse/refractory status and tumor burden, patient-specific factors including performance status and organ function, with extramedullary disease requiring careful monitoring while isolated CNS disease may warrant alternative treatments or clinical trials.

Now Viewing

EP: 1.CAR T-cell Therapy for B-ALL

Video content above is prompted by the following:

• Please provide a general overview of the CAR-T cell therapy program at your center.What disease and/or patient-specific considerations guide the selection of CAR-T?How does the presence of extramedullary disease or isolated CNS disease impact your decision?

Related Videos